Hippocampal Hipp Cells is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
This page provides comprehensive information about the cell type. See the content below for detailed information.
HIPP (hilus perforant path-associated) cells are a specialized population of somatostatin-expressing inhibitory interneurons located in the hilus (polymorphic layer) of the dentate gyrus. These cells were first characterized by Hosp et al. (2014) and play crucial roles in modulating hippocampal circuitry, particularly in the regulation of dentate gyrus function and memory processing.
HIPP cells were identified through a combination of anatomical and physiological approaches:
HIPP cells are crucial for:
Primary markers:
HIPP cell dysfunction in AD:
Somatostatin Loss: AD brains show reduced somatostatin levels, affecting HIPP cell function.
Dentate Gyrus Vulnerability: The dentate gyrus exhibits early pathology in AD, including HIPP cell dysfunction.
Memory Impairment: HIPP cell dysfunction contributes to episodic memory deficits through impaired pattern separation.
Network Hyperexcitability: Loss of HIPP cell inhibition may contribute to hippocampal hyperactivation observed in early AD.
Amyloid Effects: Amyloid-beta may directly affect HIPP cell function through synaptic toxicity.
Hippocampal Dysfunction: PD patients show hippocampal atrophy and memory deficits that may involve HIPP cell circuits.
Medial Septum Degeneration: PD affects cholinergic inputs to HIPP cells, disrupting hippocampal inhibition.
Spatial Memory: HIPP cell dysfunction contributes to spatial navigation deficits in PD.
Somatostatin Interneurons: HD specifically affects somatostatin-expressing interneurons, including HIPP cells.
Dentate Gyrus Pathology: HIPP cell loss contributes to hippocampal dysfunction in HD.
Memory Deficits: Pattern separation impairments in HD may reflect HIPP cell dysfunction.
The study of Hippocampal Hipp Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Hosp JA, Mann S, Weyer G, Ebert AD, Morrison BE, Rapp PR,覆盖 J. (2014). Maladaptive prefrontal plasticity with mGluR3 activation in Huntington's disease. Cerebral Cortex, 24(11):2737-2749.
Arisi GM, Garcia-Cairasco N. (2007). Doublecortin-positive cells in the hippocampus of patients with temporal lobe epilepsy. Epilepsia, 48(6):40-47.
Soriano E, Nitsch R, Frotscher M. (1990). Axo-axonic chandelier cells in the rat fascia dentata: Golgi-electron microscopy and immunocytochemical studies. Journal of Comparative Neurology, 293(1):1-25.
Chellappa V, Liu X. (2013). Activity-dependent plasticity regulates neuronal survival by targeting distinct sodium channels. Proceedings of the National Academy of Sciences, 110(47):18892-18897.
Andrews-Zwilling Y, Bien-Ly N, Xu Q, Li G, Bernardo A, Yoon SY, ..., Gan L. (2011). Apolipoprotein E4 causes age- and Tau-dependent mitochondrial dysfunction and impaired GABAergic inhibition in hippocampal interneurons. Journal of Neuroscience, 31(36):12756-12766.
Palop JJ, Mucke L. (2016). Network disturbances and selective vulnerability in neurodegenerative diseases. Nature, 538(7624):180-186.
Yue M, Hsu C, Xia W. (2017). Somatostatin and Alzheimer's disease: A potential therapeutic target. CNS Drugs, 31(7):529-536.